Asia Pacific 3D Bioprinting 麻豆原创 2021-2031 by Component , Material , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM1222004

Publication Date:

December 30, 2022

Pages:

129

Publisher:

Grace 麻豆原创 Data

Countries:

Asia Pacific [1]

USD 2,380.00

Artificial Intelligence [2]

Computing & Electronics [3]

Description:

Asia Pacific 3D Bioprinting market will grow by 21.9% annually with a total addressable market cap of $7,456.1 million over 2022-2031, driven by the increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to the aging population, the rising requirement for regenerative medicines/cancer therapeutics/stem cell solutions, the rising governments and private funding, and the technological advancements such as the development of AI and organ-on-a-chip.
Highlighted with 39 tables and 56 figures, this 130-page report 鈥淎sia Pacific 3D Bioprinting 麻豆原创 2021-2031 by Component (Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices), Technology (Inkjet, Laser-assisted, Magnetic, Microextrusion), Application (Research, Clinical), End User (Research Organization, Biopharma Companies, Hospitals), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific 3D Bioprinting market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific 3D Bioprinting market in every aspect of the classification from perspectives of Component, Material, Technology, Application, End User, and Country.

Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� 3D Bioprinters
鈥� Bioinks
o Natural Bioinks
o Hybrid Bioinks
o Synthetic Bioinks

Based on Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Living Cells
鈥� Hydrogels
鈥� Extracellular Matrices
鈥� Other Material Types

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Inkjet 3D Bioprinting
鈥� Laser-assisted Bioprinting
鈥� Magnetic 3D Bioprinting
鈥� Microextrusion Bioprinting
鈥� Other Technologies

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Research Application
o Drug Research
o Regenerative Medicine
o 3D Cell Culture
鈥� Clinical Application
o Skin
o Bone and Cartilage
o Blood Vessels
o Other Clinical Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Research Organization & Academic Institutes
鈥� Biopharmaceutical Companies
鈥� Hospitals
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Material and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
3D Bio-printing Solutions
3D Systems Inc.
3DBio Therapeutics
Advanced Solutions Life Sciences LLC (ASI)
Aspect Biosystems Ltd.
Bico Group AB
Brinter
Cellink AB
CollPlant Biotechnologies Ltd.
Cyfuse Biomedical K. K.
Digilab Inc.
EnvisionTEC GmbH (Desktop Metal Inc.)
Foldink Life Science Technologies
GeSiM 鈥� Gesellschaft f眉r Silizium-Mikrosysteme mbH
Inventia Life Science Pty Ltd.
Nano3D Biosciences Inc.
Organovo Holdings Inc
Pandorum Technologies Pvt. Ltd.
Poietis
Precise Bio
Prellis Biologics
Regemat 3D S.L.
RegenHU SA
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
ROKIT Healthcare, INC.
Stratasys Ltd.
TeVido BioDevices, Inc.
Vivax Bio, LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 24
2.2 Major Growth Drivers 26
2.3 麻豆原创 Restraints and Challenges 32
2.4 Emerging Opportunities and 麻豆原创 Trends 35
2.5 Porter鈥檚 Fiver Forces Analysis 39
3 Segmentation of Asia Pacific 麻豆原创 by Component 43
3.1 麻豆原创 Overview by Component 43
3.2 3D Bioprinters 45
3.3 Bioinks 48
4 Segmentation of Asia Pacific 麻豆原创 by Material 50
4.1 麻豆原创 Overview by Material 50
4.2 Living Cells 52
4.3 Hydrogels 53
4.4 Extracellular Matrices 54
4.5 Other Material Types 55
5 Segmentation of Asia Pacific 麻豆原创 by Technology 56
5.1 麻豆原创 Overview by Technology 56
5.2 Inkjet 3D Bioprinting 58
5.3 Laser-assisted Bioprinting 59
5.4 Magnetic 3D Bioprinting 60
5.5 Microextrusion Bioprinting 61
5.6 Other Technologies 62
6 Segmentation of Asia Pacific 麻豆原创 by Application 63
6.1 麻豆原创 Overview by Application 63
6.2 Research Application 65
6.2.1 Drug Research 66
6.2.2 Regenerative Medicine 67
6.2.3 3D Cell Culture 68
6.3 Clinical Application 69
6.3.1 Skin 70
6.3.2 Bone and Cartilage 71
6.3.3 Blood Vessels 72
6.3.4 Other Clinical Applications 73
7 Segmentation of Asia Pacific 麻豆原创 by End User 74
7.1 麻豆原创 Overview by End User 74
7.2 Research Organization & Academic Institutes 76
7.3 Biopharmaceutical Companies 77
7.4 Hospitals 78
7.5 Other End Users 79
8 Asia-Pacific 麻豆原创 2021-2031 by Country 80
8.1 Overview of Asia-Pacific 麻豆原创 80
8.2 Japan 83
8.3 China 86
8.4 Australia 88
8.5 India 90
8.6 South Korea 92
8.7 Rest of APAC Region 94
9 Competitive Landscape 96
9.1 Overview of Key Vendors 96
9.2 New Product Launch, Partnership, Investment, and M&A 99
9.3 Company Profiles 100
3D Bio-printing Solutions 100
3D Systems Inc. 102
3DBio Therapeutics 103
Advanced Solutions Life Sciences LLC (ASI) 104
Aspect Biosystems Ltd. 105
Bico Group AB 106
Brinter 107
Cellink AB 108
CollPlant Biotechnologies Ltd. 109
Cyfuse Biomedical K. K. 110
Digilab Inc. 111
EnvisionTEC GmbH (Desktop Metal Inc.) 112
Foldink Life Science Technologies 113
GeSiM 鈥� Gesellschaft f眉r Silizium-Mikrosysteme mbH 114
Inventia Life Science Pty Ltd. 115
Nano3D Biosciences Inc. 116
Organovo Holdings Inc 117
Pandorum Technologies Pvt. Ltd. 118
Poietis 119
Precise Bio 120
Prellis Biologics 121
Regemat 3D S.L. 122
RegenHU SA 123
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.) 124
ROKIT Healthcare, INC. 125
Stratasys Ltd. 126
TeVido BioDevices, Inc. 127
Vivax Bio, LLC 128
RELATED REPORTS 129

Companies Mentioned:

Selected Key Players:
3D Bio-printing Solutions
3D Systems Inc.
3DBio Therapeutics
Advanced Solutions Life Sciences LLC (ASI)
Aspect Biosystems Ltd.
Bico Group AB
Brinter
Cellink AB
CollPlant Biotechnologies Ltd.
Cyfuse Biomedical K. K.
Digilab Inc.
EnvisionTEC GmbH (Desktop Metal Inc.)
Foldink Life Science Technologies
GeSiM 鈥� Gesellschaft f眉r Silizium-Mikrosysteme mbH
Inventia Life Science Pty Ltd.
Nano3D Biosciences Inc.
Organovo Holdings Inc
Pandorum Technologies Pvt. Ltd.
Poietis
Precise Bio
Prellis Biologics
Regemat 3D S.L.
RegenHU SA
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
ROKIT Healthcare, INC.
Stratasys Ltd.
TeVido BioDevices, Inc.
Vivax Bio, LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.